Richard K. Rosenberg

p53: A Frequent Target for Genetic Abnormalities in Lung Cancer

Takashi Takahashi, Marion M. Nau, Itsuo Chiba et al. · Science · 1989 · 1.2K citations

Tumor Biology, Oncology, Medicine +14

The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells.

Rhoda M. Alani, Powel H. Brown, Bernard Binétruy et al. · Molecular and Cellular Biology · 1991 · 126 citations · Full text

Genetics, Cellular Physiology, C-jun Protein +20

Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer

Giorgio V. Scagliotti, Jin Hyoung Kang, David C. Smith et al. · Investigational New Drugs · 2016 · 68 citations

Phase Ii Evaluation, Oncology, Medicine +6

Whole‐genome Sequencing of an Aggressive BRAF Wild‐type Papillary Thyroid Cancer Identified EML4–ALK Translocation as a Therapeutic Target

Michael J. Demeure, Meraj Aziz, Richard K. Rosenberg et al. · World Journal of Surgery · 2014 · 58 citations

Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.

Everett E. Vokes, Richard K. Rosenberg, Mohammad Jahanzeb et al. · Journal of Clinical Oncology · 1995 · 43 citations